Prosecution Insights
Last updated: September 17, 2026
Application No. 18/284,917

COMPOSITE POWDER AND COSMETIC CONTAINING SAME

Final Rejection §102§103§112
Filed
Sep 29, 2023
Priority
Mar 31, 2021 — JP 2021-060853 +1 more
Examiner
WRIGHT, SARAH C
Art Unit
1619
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Matsumoto Trading Co. Ltd.
OA Round
2 (Final)
41%
Grant Probability
Moderate
3-4
OA Rounds
5m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allowance Rate
233 granted / 565 resolved
-18.8% vs TC avg
Strong +46% interview lift
Without
With
+46.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
36 currently pending
Career history
623
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
56.2%
+16.2% vs TC avg
§102
9.5%
-30.5% vs TC avg
§112
16.2%
-23.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 565 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-9 are pending. Claims 4-5 and 9 are amended. Claim 9 is withdrawn as being drawn to a non-elected invention or species, there being no linking or generic claim. Claims 1-8 are examined on their merits. Information Disclosure Statement The IDS filed 7/29/2026 has been reviewed. Previous Rejections Rejections and/or objections not reiterated from previous office actions are hereby withdrawn as are those rejections and/or objections expressly stated to be withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Rejections Withdrawn Claim Rejections - 35 USC §112(b) In light of the amendments to the claims the rejection of claims 4-5 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Rejections Maintained Claim Rejections - 35 USC §102(a)(1) The following is a quotation of 35 U.S.C. 102(a)(1): (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. The rejection of claims 1, 7 and 8 under 35 U.S.C. 102(a)(1) as being anticipated by Taizo et al. US 5968531 (10/19/1999)(9/26/2025 IDS) as evidenced by ZME Science (The Mica minerals: geology, characteristics, types and uses) and the instant specification is maintained. Taizo et al. (Taizo) teaches a particulate composite comprising a substrate particles surrounded by a plurality of metal oxide particles bound to the surface of the substrate particle by a binding agent that can be a hydrogenated vegetable or animal oil. (See Abstract and Example 2). The substrate particle can be mica and the metal oxide particles can be zinc oxide. (See Taizo claims 1-2). Taizo discloses in Example 2 micronized mica which is mixed with micronized zinc oxide and hydrogenated egg oil. (See Example 2). A composite powder is produced in which the micronized zinc oxide (a spherical powder as taught in col. 1, lines 40 to 65 of Taizo) is coated with hydrogenated egg oil (an oil agent) and micronized mica is adhered to the zinc oxide powder. (See Example 2). Micronized mica has a plate-like shape as evidenced by ZME Science (The Mica minerals: geology, characteristics, types and uses). Taizo teaches mica and zinc oxide and hydrogenated egg oil and Example 2 does not contain plastic microbeads as called for in instant claim 8. Example 3 is a compressed powder foundation cosmetic containing the composite powder as called for in instant claim 7. Taizo thus teaches each and every element of claims 1, 7 and 8. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. The rejection of claims 1-8 under 35 U.S.C. 103 as being unpatentable over Taizo et al. US 5968531 (10/19/1999)(9/26/2025 IDS) as evidenced by ZME Science (The Mica minerals: geology, characteristics, types and uses) and the instant specification is maintained. Taizo et al. (Taizo) teaches a particulate composite comprising a substrate particles surrounded by a plurality of metal oxide particles bound to the surface of the substrate particle by a binding agent that can be a hydrogenated vegetable or animal oil. (See Abstract and Example 2). The substrate particle can be mica and the metal oxide particles can be zinc oxide. (See Taizo claims 1-2). Taizo discloses in Example 2 micronized mica which is mixed with micronized zinc oxide and hydrogenated egg oil. (See Example 2). A composite powder is produced in which the micronized zinc oxide (a spherical powder as taught in col. 1, lines 40 to 65) is coated with hydrogenated egg oil (an oil agent) and micronized mica is adhered to the zinc oxide powder. (See Example 2). Micronized mica has a plate-like shape as evidenced by ZME Science (The Mica minerals: geology, characteristics, types and uses. Taizo teaches that the diameter of the mica is 5.8 micrometers (expressed as microns). (See Example 2). Taizo teaches that for cosmetics, an aspect ratio of at least 10 is suitable for most cosmetic formulations. (See col. 3, lines 15-20). 5.8 micrometers is less than 50 micrometers as called for in instant claims 3 and 5. An aspect ratio of less than 10 overlaps with the aspect ratio of 2 to 200 called for in instant claim 3. Hydrogenated vegetable or animal oils are semi-solid as evidenced by the instant specification at [0020]. Thus hydrogenated egg oil is a semi-solid as called for in instant claim 4. Taizo teaches that the platelet like particle such as mica can be from 1 to 20 microns. The metal oxide particles such as zinc oxide should be less than or equal to one-tenth of the mean particle size of the mica or substrate particles. Thus, the zinc oxide can be 2 microns or less which overlaps with the 1 to 20 microns called for in instant claims 2 and 5. Taizo teaches that the proportion of the particles of metal oxide to substrate particles depends on the desired degree of coating of the substrate particles as well as the relative sizes of the two types of particles. (See column 4). The metal oxide can be between 10 and 30%, the hydrogenated oil binding agent can be between 0.5 and 5% and the mica particles can depend on the desired degree of coating. (See Abstract and Example 2 and Examples). Taizo thus teaches that the amount of metal oxide to binding agent to mica particles can be varied since it is a results-effective variable, the result being the desired degree of coating. It would be no more than routine experimentation to experiment to arrive at the claimed ratios of 99.8/0.1/0.1 to 1/1/1 in claim 6. Taizo teaches mica and zinc oxide and hydrogenated egg oil and Example 2 does not contain plastic microbeads as called for in instant claim 8. Example 3 is a compressed powder foundation cosmetic containing the composite powder as called for in instant claim 7. Taizo teaches that its composite powder has a smooth, lubricious feel on the skin and also retains its transparency. (See col. 2). It would have been prima facie obvious for one of ordinary skill in the art before the earliest effective filing date making the Taizo cosmetic composition to use a composite powder that is produced by micronized spherical zinc oxide of 2 microns or less being coated with hydrogenated egg oil and adhering micronized mica of 5.8 microns and an aspect ratio of less than 10 to the coated zinc oxide in order to have a cosmetic with a composite powder that has a smooth, lubricious feel on the skin and also retains its transparency. Response to Arguments Applicants’ comments of May 18, 2026 have been considered carefully and are found unpersuasive for the reasons described below. Applicants note the amendments to the claims and where support can be found for the amendments. Applicants argue that the rejections over Taizo appear to be based on a misinterpretation of Taizo. Applicants assert that the mica substrate particles in Taizo Example 2 are nearly 300 times as large as the micronized ZnO particles, and therefore Taizo fails to disclose the essential structural feature of claim 1 – composite particles structure wherein a plate-like powder is adhered to a spherical powder coated with an oil agent- claim 1 is not anticipated by Taizo or obvious over Taizo. Applicants assert that Taizo teaches away from claim 1 by explicitly requiring non-spherical (plate-like) substrates as the core, teaching that this shape provides desirable properties for cosmetic application. This is at odds with Applicants’ instant objective technical problem of how to modify a composite powder to provide an alternative to plastic microbeads that replicates their advantages in a cosmetic formulation. Applicants’ arguments have been carefully reviewed and are not found to be persuasive. With respect to the anticipation rejection, as described in the rejection above, Taizo discloses in Example 2 micronized mica which is mixed with micronized zinc oxide and hydrogenated egg oil. (See Example 2). A composite powder is produced in which the micronized zinc oxide (a spherical powder as taught in col. 1, lines 40 to 65 of Taizo) is coated with hydrogenated egg oil (an oil agent) and micronized mica is adhered to the zinc oxide powder. (See Example 2). The micronized mica is adhered to the zinc oxide powder. Claim 1 teaches a spherical powder which is coated in an oil agent and then the plate like substance is adhered to it. Taizo teaches a cosmetic with this composite powder as called for in claim 7, and the cosmetic does not contain microbeads as called for in claim 8. Additionally, with respect to the anticipation rejection, applicants’ assertion that Taizo teaches away from claim 1 by explicitly requiring non-spherical (plate-like) substrates as the core is also not found to be persuasive. "Arguments that the alleged anticipatory prior art is ‘nonanalogous art’ or ‘teaches away from the invention’ or is not recognized as solving the problem solved by the claimed invention, [are] not ‘germane’ to a rejection under section 102." Twin Disc, Inc. v. United States, 231 USPQ 417, 424 (Cl. Ct. 1986) (quoting In re Self, 671 F.2d 1344, 213 USPQ 1, 7 (CCPA 1982)). A reference is no less anticipatory if, after disclosing the invention, the reference then disparages it. The question whether a reference "teaches away" from the invention is inapplicable to an anticipation analysis. Celeritas Technologies Ltd. v. Rockwell International Corp., 150 F.3d 1354, 1361, 47 USPQ2d 1516, 1522-23 (Fed. Cir. 1998). Regarding the arguments relating to the obviousness rejection, Applicants’ assertion that Taizo teaches away from claim 1 by explicitly requiring non-spherical (plate-like) substrates as the core is not found to be persuasive. Applicants’ assertion that Taizo teaches away is not found to be persuasive because there is absolutely no discouragement or disparagement of adhering a plate-like powder to a spherical powder coated with an oil agent in Taizo. Quite the opposite, actually. Taizo teaches the benefits of coating a micronized spherical zinc oxide of 2 microns or less with hydrogenated egg oil and adhering micronized mica of 5.8 microns to the coated zinc oxide include the ability for the composite powder to retain its transparency and provide a cosmetic with a good, smooth, lubricious feel on the skin. A teaching away must be clear. See MPEP Sec. 2143.03 (VI). Additionally, it should be noted that there is no requirement regarding a core in instant claim 1, so it is unclear what requirement Applicants are referring to, since no such requirement exists in the language of the claims. The only size requirements recited in the claims are taught by Taizo. Namely, Taizo teaches a cosmetic composition with a composite powder that is produced by micronized spherical zinc oxide of 2 microns or less being coated with hydrogenated egg oil and adhering micronized mica of 5.8 microns and an aspect ratio of less than 10 to the coated zinc oxide in order to have a cosmetic with a transparent composite powder that has a good smooth feel on the skin. Additionally, it is not necessary that the prior art teach the same benefit or advantage that Applicants found for there to be a prima facie case of obviousness. The reason or motivation to modify the reference may often suggest what the inventor has done, but for a different purpose or to solve a different problem. The purpose in this instance is to have a cosmetic with a composite powder that has a smooth, lubricious feel on the skin and also retains its transparency. It is not necessary that the prior art suggest the combination to achieve the same advantage or result is covered by applicant. See, e.g., In re Kahn, 441 F.3d 977, 987, 78 USPQ2d 1329, 1336 (Fed. Cir. 2006) (motivation question arises in the context of the general problem confronting the inventor rather than the specific problem solved by the invention); Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 1323, 76 USPQ2d 1662, 1685 (Fed. Cir. 2005) (“One of ordinary skill in the art need not see the identical problem addressed in a prior art reference to be motivated to apply its teachings.”); In re Linter, 458 F.2d 1013, 173 USPQ 560 (CCPA 1972) (discussed below); In re Dillon, 919 F.2d 688, 16 USPQ2d 1897 (Fed. Cir. 1990), cert. denied, 500 U.S. 904 (1991). As described in the obviousness rejection above, it would have been prima facie obvious before the effective filing date of the claimed invention for one of ordinary skill in the art making the Taizo cosmetic composition to use a composite powder that is produced by micronized spherical zinc oxide of 2 microns or less being coated with hydrogenated egg oil and adhering micronized mica of 5.8 microns and an aspect ratio of less than 10 to the coated zinc oxide in order to have a cosmetic with a composite powder that has a smooth, lubricious feel on the skin and also retains its transparency. Conclusion No claims are allowed. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SARAH CHICKOS whose telephone number is (571)270-3884. The examiner can normally be reached on M-F 9-6. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Blanchard can be reached on 571-272-0827. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. SARAH CHICKOS Examiner Art Unit 1619 /DAVID J BLANCHARD/ Supervisory Patent Examiner, Art Unit 1619
Read full office action

Prosecution Timeline

Sep 29, 2023
Application Filed
Feb 25, 2026
Non-Final Rejection mailed — §102, §103, §112
May 18, 2026
Response Filed
Aug 26, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12653779
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
2y 9m to grant Granted Jun 16, 2026
Patent 12629327
KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS
2y 9m to grant Granted May 19, 2026
Patent 12629340
MODIFIED RELEASE COMPOSITION OF ORLISTAT AND ACARBOSE FOR THE TREATMENT OF OBESITY AND RELATED METABOLIC DISORDERS
2y 1m to grant Granted May 19, 2026
Patent 12558372
POLYHYDROXYALKANOATES FOR USE IN THE PREVENTION OR TREATMENT OF AN OVERWEIGHT OR OBESITY CONDITION, OR OF METABOLIC DYSFUNCTIONS RELATED TO SAID CONDITION
5y 1m to grant Granted Feb 24, 2026
Patent 12558303
MANUFACTURE, ISOLATION, PURIFICATION, AND USES OF SMALL PARTICLE SIZE CELLULOSE PARTICLES AND COMPOSITIONS
2y 8m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
41%
Grant Probability
88%
With Interview (+46.4%)
3y 5m (~5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 565 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month